Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
NCT00635128
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
415
Enrollment
INDUSTRY
Sponsor class
Conditions
Poliomyelitis
Diphtheria
Tetanus
Acellular Pertussis
Interventions
BIOLOGICAL:
Boostrix-Polio
Sponsor
GlaxoSmithKline